Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
236.99
+12.11 (5.39%)
Last updated: Mar 28, 2025

SHA:688506 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
99,04376,88456,100---
Upgrade
Market Cap Growth
37.05%37.05%----
Upgrade
Enterprise Value
97,89173,45856,019---
Upgrade
Last Close Price
246.99191.73139.90---
Upgrade
PE Ratio
26.7020.74----
Upgrade
PS Ratio
17.0013.2099.85---
Upgrade
PB Ratio
25.4519.79369.39---
Upgrade
P/TBV Ratio
19.9219.92452.87---
Upgrade
P/FCF Ratio
24.9219.34----
Upgrade
P/OCF Ratio
18.9418.94----
Upgrade
EV/Sales Ratio
16.8112.6299.70---
Upgrade
EV/EBITDA Ratio
25.6819.27----
Upgrade
EV/EBIT Ratio
26.1519.62----
Upgrade
EV/FCF Ratio
24.6318.48----
Upgrade
Debt / Equity Ratio
0.530.534.530.590.870.33
Upgrade
Debt / EBITDA Ratio
0.540.54---5.68
Upgrade
Debt / FCF Ratio
0.520.52---2.38
Upgrade
Asset Turnover
1.361.360.330.480.800.95
Upgrade
Inventory Turnover
1.751.752.002.592.752.82
Upgrade
Quick Ratio
1.711.710.521.730.620.89
Upgrade
Current Ratio
3.193.190.741.940.901.07
Upgrade
Return on Equity (ROE)
183.64%183.64%-143.77%-44.62%-25.51%8.62%
Upgrade
Return on Assets (ROA)
54.65%54.65%-28.74%-14.01%-10.00%-1.34%
Upgrade
Return on Capital (ROIC)
68.87%68.87%-42.30%-19.63%-16.33%-2.33%
Upgrade
Return on Capital Employed (ROCE)
72.60%72.60%----
Upgrade
Earnings Yield
3.74%4.82%-1.39%---
Upgrade
FCF Yield
4.01%5.17%-1.24%---
Upgrade
Payout Ratio
1.03%1.03%---26.28%
Upgrade
Buyback Yield / Dilution
-0.14%-0.14%-10.56%-1.38%-3.64%10.86%
Upgrade
Total Shareholder Return
-0.14%-0.14%-10.56%-1.38%-3.64%10.86%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.